2014

1. 18F-FDG PET-CT imaging in the neoadjuvant setting for stages II-III breast cancer: Association of loco-regional SUVmax with classical prognostic factors

   Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 58, Núm. 1, pp. 66-73

2. Predictive value of PET-CT for pathological response in stages II and III breast cancer patients following neoadjuvant chemotherapy with docetaxel

   Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 33, Núm. 1, pp. 14-21